The tuberculin skin test (TST) or Mantoux reaction (MR) has been used worldwide in the diagnosis of M. tuberculosis infection for over 100 years. Many regions have experienced shortages of the purified protein derivative (PPD) TST in recent years as the number of suppliers has decreased. The accuracy of the PPD TST is limited by prior BCG vaccination, infection by other non-tuberculous mycobacteria, reduced sensitivity in immunocompromised hosts with a high risk of tuberculosis (TB) such as HIV, and limited ability to diagnose active TB. We previously described a recombinant protein (‘DPPD’) derived from M. tuberculosis (MTB) that can replace the classical PPD antigen used in TST.
We compared DDPD to PPD using MR in a population of 672 people in the state of Bahia, Brazil. Participants were divided among 5 specific groups: Group 1 – 232 BCG-vaccinated individuals with no signs or symptoms nor history of active TB; Group 2 – 40 HIV-negative patients with active TB as defined by a clinical isolate with a positive culture for MTB or positive acid fast stain; Group 3 – 38 HIV-positive individuals with active TB and MTB found on culture a positive acid fast stain; Group 4 – 182 HIV-positive patients with signs and symptoms compatible with active TB, but without microbiologic confirmation, who responded to drug therapy for TB; Group 5 – 115 HIV-negative patients with a clinical diagnosis of active TB, without microbioloigc confirmation of MTB, who responded to drug therapy for active TB. PPD and DPPD were applied intradermally in contralateral arms using a standard Mantoux test technique.
Among healthy people previously vaccinated with BCG (Group 1), 57% had positive PPD and 41% had positive DPPD with a good concordance index (Kappa = 0.90). In the context of active TB, DPPD was positive in 93% of patients with active co-infection HIV and TB (Groups 3 and 4), compared to 50% of PPD (p <0.001). All (100%) of HIV negative patients with active TB (Groups 2 and 5) were both DPPD and PPD positive. No differences were noted when microbiologically-confirmed cases were compared to clinically-confirmed cases of active TB. Among HIV-positive patients with active TB, DPPD was significantly more sensitive than PPD when stratified by CD4 cell counts (P=0.0001).
The recombinant DPPD antigen may be an important tool in the diagnosis and control of TB, with improved sensitivity and enhanced specificity compared with PPD.